nodes	percent_of_prediction	percent_of_DWPC	metapath
Crizotinib—SBK3—adipose tissue—gestational diabetes	0.0108	0.018	CbGeAlD
Crizotinib—PRKD3—islet of Langerhans—gestational diabetes	0.00659	0.011	CbGeAlD
Crizotinib—PRKD3—embryo—gestational diabetes	0.00637	0.0106	CbGeAlD
Crizotinib—MET—islet of Langerhans—gestational diabetes	0.0057	0.00949	CbGeAlD
Crizotinib—MET—embryo—gestational diabetes	0.00551	0.00918	CbGeAlD
Crizotinib—ACVR1B—islet of Langerhans—gestational diabetes	0.00527	0.00877	CbGeAlD
Crizotinib—ANKK1—head—gestational diabetes	0.00514	0.00856	CbGeAlD
Crizotinib—ACVR1B—embryo—gestational diabetes	0.00509	0.00848	CbGeAlD
Crizotinib—DCLK1—embryo—gestational diabetes	0.00483	0.00804	CbGeAlD
Crizotinib—ALK—embryo—gestational diabetes	0.00451	0.00751	CbGeAlD
Crizotinib—PRKD1—adipose tissue—gestational diabetes	0.00437	0.00728	CbGeAlD
Crizotinib—IGF1R—embryo—gestational diabetes	0.00433	0.00721	CbGeAlD
Crizotinib—LIMK1—adipose tissue—gestational diabetes	0.00431	0.00718	CbGeAlD
Crizotinib—SIK2—adipose tissue—gestational diabetes	0.00431	0.00718	CbGeAlD
Crizotinib—PRKD3—uterus—gestational diabetes	0.0043	0.00715	CbGeAlD
Crizotinib—TESK1—islet of Langerhans—gestational diabetes	0.00421	0.00701	CbGeAlD
Crizotinib—PRKD3—adipose tissue—gestational diabetes	0.0042	0.007	CbGeAlD
Crizotinib—DSTYK—adipose tissue—gestational diabetes	0.0041	0.00683	CbGeAlD
Crizotinib—CASK—adipose tissue—gestational diabetes	0.00401	0.00668	CbGeAlD
Crizotinib—NUAK2—islet of Langerhans—gestational diabetes	0.00399	0.00665	CbGeAlD
Crizotinib—MAPK7—uterus—gestational diabetes	0.00397	0.00661	CbGeAlD
Crizotinib—ACVR1—islet of Langerhans—gestational diabetes	0.00396	0.0066	CbGeAlD
Crizotinib—FES—uterus—gestational diabetes	0.00393	0.00654	CbGeAlD
Crizotinib—STK35—islet of Langerhans—gestational diabetes	0.00388	0.00647	CbGeAlD
Crizotinib—MAPK7—adipose tissue—gestational diabetes	0.00388	0.00647	CbGeAlD
Crizotinib—FES—adipose tissue—gestational diabetes	0.00384	0.0064	CbGeAlD
Crizotinib—MET—uterus—gestational diabetes	0.00372	0.00619	CbGeAlD
Crizotinib—NEK9—head—gestational diabetes	0.00368	0.00613	CbGeAlD
Crizotinib—MET—adipose tissue—gestational diabetes	0.00363	0.00605	CbGeAlD
Crizotinib—CDK7—uterus—gestational diabetes	0.00359	0.00599	CbGeAlD
Crizotinib—LIMK1—vagina—gestational diabetes	0.00358	0.00597	CbGeAlD
Crizotinib—RIPK2—islet of Langerhans—gestational diabetes	0.00358	0.00596	CbGeAlD
Crizotinib—CDK7—adipose tissue—gestational diabetes	0.00352	0.00585	CbGeAlD
Crizotinib—PRKD3—vagina—gestational diabetes	0.00349	0.00582	CbGeAlD
Crizotinib—PTK2B—embryo—gestational diabetes	0.00349	0.00581	CbGeAlD
Crizotinib—TAOK2—adipose tissue—gestational diabetes	0.00349	0.00581	CbGeAlD
Crizotinib—ACVR1B—adipose tissue—gestational diabetes	0.00336	0.00559	CbGeAlD
Crizotinib—EPHA3—adipose tissue—gestational diabetes	0.00336	0.00559	CbGeAlD
Crizotinib—PRKD1—head—gestational diabetes	0.00336	0.00559	CbGeAlD
Crizotinib—EPHA4—embryo—gestational diabetes	0.00335	0.00557	CbGeAlD
Crizotinib—CASK—vagina—gestational diabetes	0.00333	0.00555	CbGeAlD
Crizotinib—TBK1—islet of Langerhans—gestational diabetes	0.00332	0.00554	CbGeAlD
Crizotinib—PTK2—islet of Langerhans—gestational diabetes	0.00332	0.00554	CbGeAlD
Crizotinib—SIK2—head—gestational diabetes	0.00331	0.00551	CbGeAlD
Crizotinib—TYK2—islet of Langerhans—gestational diabetes	0.0033	0.0055	CbGeAlD
Crizotinib—IRAK1—islet of Langerhans—gestational diabetes	0.00326	0.00543	CbGeAlD
Crizotinib—DCLK1—uterus—gestational diabetes	0.00326	0.00542	CbGeAlD
Crizotinib—TXK—vagina—gestational diabetes	0.00323	0.00537	CbGeAlD
Crizotinib—MAPK7—vagina—gestational diabetes	0.00323	0.00537	CbGeAlD
Crizotinib—PTK2—embryo—gestational diabetes	0.00321	0.00535	CbGeAlD
Crizotinib—JAK3—adipose tissue—gestational diabetes	0.0032	0.00534	CbGeAlD
Crizotinib—FES—vagina—gestational diabetes	0.00319	0.00532	CbGeAlD
Crizotinib—DCLK1—adipose tissue—gestational diabetes	0.00318	0.0053	CbGeAlD
Crizotinib—STK4—adipose tissue—gestational diabetes	0.00315	0.00524	CbGeAlD
Crizotinib—RPS6KB1—embryo—gestational diabetes	0.00309	0.00515	CbGeAlD
Crizotinib—LTK—head—gestational diabetes	0.00308	0.00513	CbGeAlD
Crizotinib—FGR—embryo—gestational diabetes	0.00307	0.00512	CbGeAlD
Crizotinib—SLK—islet of Langerhans—gestational diabetes	0.00305	0.00507	CbGeAlD
Crizotinib—EPHB4—islet of Langerhans—gestational diabetes	0.00303	0.00504	CbGeAlD
Crizotinib—TNK1—uterus—gestational diabetes	0.00301	0.00501	CbGeAlD
Crizotinib—MAPK7—head—gestational diabetes	0.00298	0.00496	CbGeAlD
Crizotinib—TXK—head—gestational diabetes	0.00298	0.00496	CbGeAlD
Crizotinib—BMPR1B—uterus—gestational diabetes	0.00298	0.00496	CbGeAlD
Crizotinib—FER—adipose tissue—gestational diabetes	0.00297	0.00495	CbGeAlD
Crizotinib—EPHA2—islet of Langerhans—gestational diabetes	0.00297	0.00494	CbGeAlD
Crizotinib—EPHA8—head—gestational diabetes	0.00295	0.00491	CbGeAlD
Crizotinib—TNK2—uterus—gestational diabetes	0.00292	0.00486	CbGeAlD
Crizotinib—MAP4K1—adipose tissue—gestational diabetes	0.00291	0.00485	CbGeAlD
Crizotinib—BMPR1B—adipose tissue—gestational diabetes	0.00291	0.00485	CbGeAlD
Crizotinib—JAK2—embryo—gestational diabetes	0.0029	0.00484	CbGeAlD
Crizotinib—TAOK2—vagina—gestational diabetes	0.0029	0.00483	CbGeAlD
Crizotinib—MAP4K5—islet of Langerhans—gestational diabetes	0.0029	0.00482	CbGeAlD
Crizotinib—MAP4K2—uterus—gestational diabetes	0.00288	0.0048	CbGeAlD
Crizotinib—TNK2—adipose tissue—gestational diabetes	0.00286	0.00476	CbGeAlD
Crizotinib—IGF1R—adipose tissue—gestational diabetes	0.00286	0.00476	CbGeAlD
Crizotinib—TIE1—uterus—gestational diabetes	0.00284	0.00473	CbGeAlD
Crizotinib—STK3—uterus—gestational diabetes	0.00284	0.00473	CbGeAlD
Crizotinib—MAP4K2—adipose tissue—gestational diabetes	0.00282	0.00469	CbGeAlD
Crizotinib—TEK—embryo—gestational diabetes	0.0028	0.00466	CbGeAlD
Crizotinib—MET—head—gestational diabetes	0.00279	0.00465	CbGeAlD
Crizotinib—STK3—adipose tissue—gestational diabetes	0.00278	0.00463	CbGeAlD
Crizotinib—TIE1—adipose tissue—gestational diabetes	0.00278	0.00463	CbGeAlD
Crizotinib—AURKA—uterus—gestational diabetes	0.00277	0.00461	CbGeAlD
Crizotinib—EPHB6—islet of Langerhans—gestational diabetes	0.00277	0.00461	CbGeAlD
Crizotinib—CDK7—head—gestational diabetes	0.0027	0.00449	CbGeAlD
Crizotinib—TESK1—adipose tissue—gestational diabetes	0.00269	0.00447	CbGeAlD
Crizotinib—YES1—islet of Langerhans—gestational diabetes	0.00267	0.00445	CbGeAlD
Crizotinib—DCLK1—vagina—gestational diabetes	0.00265	0.00441	CbGeAlD
Crizotinib—TAOK3—islet of Langerhans—gestational diabetes	0.00264	0.0044	CbGeAlD
Crizotinib—MERTK—adipose tissue—gestational diabetes	0.00261	0.00435	CbGeAlD
Crizotinib—LIMK2—uterus—gestational diabetes	0.00261	0.00435	CbGeAlD
Crizotinib—ACVR1—uterus—gestational diabetes	0.00258	0.0043	CbGeAlD
Crizotinib—ACVR1B—head—gestational diabetes	0.00258	0.0043	CbGeAlD
Crizotinib—EPHA3—head—gestational diabetes	0.00258	0.0043	CbGeAlD
Crizotinib—SRC—islet of Langerhans—gestational diabetes	0.00257	0.00428	CbGeAlD
Crizotinib—LIMK2—adipose tissue—gestational diabetes	0.00255	0.00425	CbGeAlD
Crizotinib—NUAK2—adipose tissue—gestational diabetes	0.00255	0.00424	CbGeAlD
Crizotinib—MAP3K12—adipose tissue—gestational diabetes	0.00253	0.00421	CbGeAlD
Crizotinib—ACVR1—adipose tissue—gestational diabetes	0.00253	0.00421	CbGeAlD
Crizotinib—SRC—embryo—gestational diabetes	0.00249	0.00414	CbGeAlD
Crizotinib—STK35—adipose tissue—gestational diabetes	0.00248	0.00412	CbGeAlD
Crizotinib—FER—vagina—gestational diabetes	0.00247	0.00412	CbGeAlD
Crizotinib—EPHA5—vagina—gestational diabetes	0.00247	0.00412	CbGeAlD
Crizotinib—EPHA6—head—gestational diabetes	0.00246	0.0041	CbGeAlD
Crizotinib—JAK3—head—gestational diabetes	0.00246	0.0041	CbGeAlD
Crizotinib—TNK1—vagina—gestational diabetes	0.00245	0.00407	CbGeAlD
Crizotinib—DCLK1—head—gestational diabetes	0.00245	0.00407	CbGeAlD
Crizotinib—MAP4K1—vagina—gestational diabetes	0.00242	0.00403	CbGeAlD
Crizotinib—STK4—head—gestational diabetes	0.00242	0.00402	CbGeAlD
Crizotinib—ABL2—adipose tissue—gestational diabetes	0.00241	0.00402	CbGeAlD
Crizotinib—BMP2K—adipose tissue—gestational diabetes	0.00238	0.00397	CbGeAlD
Crizotinib—IGF1R—vagina—gestational diabetes	0.00237	0.00395	CbGeAlD
Crizotinib—MAP4K2—vagina—gestational diabetes	0.00234	0.0039	CbGeAlD
Crizotinib—STK3—vagina—gestational diabetes	0.00231	0.00385	CbGeAlD
Crizotinib—PTK2B—adipose tissue—gestational diabetes	0.0023	0.00383	CbGeAlD
Crizotinib—RIPK2—adipose tissue—gestational diabetes	0.00228	0.0038	CbGeAlD
Crizotinib—ALK—head—gestational diabetes	0.00228	0.0038	CbGeAlD
Crizotinib—EPHA5—head—gestational diabetes	0.00228	0.0038	CbGeAlD
Crizotinib—FER—head—gestational diabetes	0.00228	0.0038	CbGeAlD
Crizotinib—TYRO3—head—gestational diabetes	0.00228	0.0038	CbGeAlD
Crizotinib—LYN—head—gestational diabetes	0.00227	0.00378	CbGeAlD
Crizotinib—EPHA4—uterus—gestational diabetes	0.00226	0.00376	CbGeAlD
Crizotinib—AURKA—vagina—gestational diabetes	0.00225	0.00375	CbGeAlD
Crizotinib—BMPR1B—head—gestational diabetes	0.00224	0.00372	CbGeAlD
Crizotinib—MAP3K19—head—gestational diabetes	0.00224	0.00372	CbGeAlD
Crizotinib—CSF1R—embryo—gestational diabetes	0.00223	0.00372	CbGeAlD
Crizotinib—TESK1—vagina—gestational diabetes	0.00223	0.00372	CbGeAlD
Crizotinib—MAP3K2—uterus—gestational diabetes	0.00221	0.00369	CbGeAlD
Crizotinib—EPHA4—adipose tissue—gestational diabetes	0.00221	0.00368	CbGeAlD
Crizotinib—IGF1R—head—gestational diabetes	0.00219	0.00365	CbGeAlD
Crizotinib—TNK2—head—gestational diabetes	0.00219	0.00365	CbGeAlD
Crizotinib—MERTK—vagina—gestational diabetes	0.00217	0.00362	CbGeAlD
Crizotinib—PTK2—uterus—gestational diabetes	0.00217	0.00361	CbGeAlD
Crizotinib—MAP3K2—adipose tissue—gestational diabetes	0.00216	0.0036	CbGeAlD
Crizotinib—TYK2—uterus—gestational diabetes	0.00215	0.00359	CbGeAlD
Crizotinib—STK3—head—gestational diabetes	0.00213	0.00355	CbGeAlD
Crizotinib—TIE1—head—gestational diabetes	0.00213	0.00355	CbGeAlD
Crizotinib—LIMK2—vagina—gestational diabetes	0.00212	0.00354	CbGeAlD
Crizotinib—PTK2—adipose tissue—gestational diabetes	0.00212	0.00353	CbGeAlD
Crizotinib—TBK1—adipose tissue—gestational diabetes	0.00212	0.00353	CbGeAlD
Crizotinib—NUAK2—vagina—gestational diabetes	0.00212	0.00352	CbGeAlD
Crizotinib—TYK2—adipose tissue—gestational diabetes	0.00211	0.00351	CbGeAlD
Crizotinib—ACVR1—vagina—gestational diabetes	0.0021	0.0035	CbGeAlD
Crizotinib—MAP3K12—vagina—gestational diabetes	0.0021	0.0035	CbGeAlD
Crizotinib—AURKA—head—gestational diabetes	0.00208	0.00346	CbGeAlD
Crizotinib—IRAK1—adipose tissue—gestational diabetes	0.00208	0.00346	CbGeAlD
Crizotinib—LCK—uterus—gestational diabetes	0.00207	0.00345	CbGeAlD
Crizotinib—AXL—uterus—gestational diabetes	0.00206	0.00344	CbGeAlD
Crizotinib—TESK1—head—gestational diabetes	0.00206	0.00343	CbGeAlD
Crizotinib—STK35—vagina—gestational diabetes	0.00206	0.00343	CbGeAlD
Crizotinib—RPS6KB1—adipose tissue—gestational diabetes	0.00204	0.0034	CbGeAlD
Crizotinib—LCK—adipose tissue—gestational diabetes	0.00203	0.00338	CbGeAlD
Crizotinib—FGR—adipose tissue—gestational diabetes	0.00203	0.00338	CbGeAlD
Crizotinib—AXL—adipose tissue—gestational diabetes	0.00202	0.00336	CbGeAlD
Crizotinib—ABL2—vagina—gestational diabetes	0.00201	0.00334	CbGeAlD
Crizotinib—MERTK—head—gestational diabetes	0.00201	0.00334	CbGeAlD
Crizotinib—SLK—uterus—gestational diabetes	0.00199	0.00331	CbGeAlD
Crizotinib—BMP2K—vagina—gestational diabetes	0.00198	0.0033	CbGeAlD
Crizotinib—EPHB4—uterus—gestational diabetes	0.00197	0.00329	CbGeAlD
Crizotinib—LIMK2—head—gestational diabetes	0.00196	0.00327	CbGeAlD
Crizotinib—SLK—adipose tissue—gestational diabetes	0.00194	0.00324	CbGeAlD
Crizotinib—MAP3K12—head—gestational diabetes	0.00194	0.00323	CbGeAlD
Crizotinib—ACVR1—head—gestational diabetes	0.00194	0.00323	CbGeAlD
Crizotinib—EPHB4—adipose tissue—gestational diabetes	0.00193	0.00321	CbGeAlD
Crizotinib—JAK2—adipose tissue—gestational diabetes	0.00192	0.00319	CbGeAlD
Crizotinib—PTK2B—vagina—gestational diabetes	0.00191	0.00319	CbGeAlD
Crizotinib—STK35—head—gestational diabetes	0.0019	0.00317	CbGeAlD
Crizotinib—RIPK2—vagina—gestational diabetes	0.0019	0.00316	CbGeAlD
Crizotinib—EPHA2—adipose tissue—gestational diabetes	0.00189	0.00315	CbGeAlD
Crizotinib—MAP4K5—uterus—gestational diabetes	0.00189	0.00314	CbGeAlD
Crizotinib—TEK—uterus—gestational diabetes	0.00189	0.00314	CbGeAlD
Crizotinib—MAP4K5—adipose tissue—gestational diabetes	0.00185	0.00307	CbGeAlD
Crizotinib—TEK—adipose tissue—gestational diabetes	0.00185	0.00307	CbGeAlD
Crizotinib—MAP3K3—adipose tissue—gestational diabetes	0.00185	0.00307	CbGeAlD
Crizotinib—EPHA4—vagina—gestational diabetes	0.00183	0.00306	CbGeAlD
Crizotinib—BMP2K—head—gestational diabetes	0.00183	0.00305	CbGeAlD
Crizotinib—ABL1—islet of Langerhans—gestational diabetes	0.00183	0.00304	CbGeAlD
Crizotinib—PTK2B—head—gestational diabetes	0.00177	0.00294	CbGeAlD
Crizotinib—ABL1—embryo—gestational diabetes	0.00177	0.00294	CbGeAlD
Crizotinib—EPHB6—adipose tissue—gestational diabetes	0.00176	0.00294	CbGeAlD
Crizotinib—PTK2—vagina—gestational diabetes	0.00176	0.00293	CbGeAlD
Crizotinib—TBK1—vagina—gestational diabetes	0.00176	0.00293	CbGeAlD
Crizotinib—RIPK2—head—gestational diabetes	0.00175	0.00292	CbGeAlD
Crizotinib—TYK2—vagina—gestational diabetes	0.00175	0.00292	CbGeAlD
Crizotinib—YES1—uterus—gestational diabetes	0.00174	0.0029	CbGeAlD
Crizotinib—STK10—uterus—gestational diabetes	0.00173	0.00288	CbGeAlD
Crizotinib—TAOK3—uterus—gestational diabetes	0.00172	0.00287	CbGeAlD
Crizotinib—YES1—adipose tissue—gestational diabetes	0.00171	0.00284	CbGeAlD
Crizotinib—RPS6KB1—vagina—gestational diabetes	0.0017	0.00282	CbGeAlD
Crizotinib—EPHA4—head—gestational diabetes	0.0017	0.00282	CbGeAlD
Crizotinib—STK10—adipose tissue—gestational diabetes	0.00169	0.00281	CbGeAlD
Crizotinib—FGR—vagina—gestational diabetes	0.00169	0.00281	CbGeAlD
Crizotinib—LCK—vagina—gestational diabetes	0.00169	0.00281	CbGeAlD
Crizotinib—TAOK3—adipose tissue—gestational diabetes	0.00168	0.0028	CbGeAlD
Crizotinib—AXL—vagina—gestational diabetes	0.00168	0.00279	CbGeAlD
Crizotinib—MAP3K2—head—gestational diabetes	0.00166	0.00277	CbGeAlD
Crizotinib—SRC—adipose tissue—gestational diabetes	0.00164	0.00273	CbGeAlD
Crizotinib—PTK2—head—gestational diabetes	0.00163	0.00271	CbGeAlD
Crizotinib—TBK1—head—gestational diabetes	0.00163	0.00271	CbGeAlD
Crizotinib—TYK2—head—gestational diabetes	0.00162	0.00269	CbGeAlD
Crizotinib—SLK—vagina—gestational diabetes	0.00162	0.00269	CbGeAlD
Crizotinib—EPHB4—vagina—gestational diabetes	0.0016	0.00267	CbGeAlD
Crizotinib—JAK2—vagina—gestational diabetes	0.00159	0.00265	CbGeAlD
Crizotinib—EPHA2—vagina—gestational diabetes	0.00157	0.00262	CbGeAlD
Crizotinib—RPS6KB1—head—gestational diabetes	0.00157	0.00261	CbGeAlD
Crizotinib—FGR—head—gestational diabetes	0.00156	0.00259	CbGeAlD
Crizotinib—AXL—head—gestational diabetes	0.00155	0.00258	CbGeAlD
Crizotinib—MAP4K5—vagina—gestational diabetes	0.00153	0.00256	CbGeAlD
Crizotinib—MAP3K3—vagina—gestational diabetes	0.00153	0.00256	CbGeAlD
Crizotinib—CSF1R—uterus—gestational diabetes	0.00151	0.00251	CbGeAlD
Crizotinib—CSF1R—adipose tissue—gestational diabetes	0.00147	0.00245	CbGeAlD
Crizotinib—JAK2—head—gestational diabetes	0.00147	0.00245	CbGeAlD
Crizotinib—EPHB6—vagina—gestational diabetes	0.00147	0.00244	CbGeAlD
Crizotinib—EPHA2—head—gestational diabetes	0.00145	0.00242	CbGeAlD
Crizotinib—MAP4K5—head—gestational diabetes	0.00142	0.00236	CbGeAlD
Crizotinib—MAP3K3—head—gestational diabetes	0.00142	0.00236	CbGeAlD
Crizotinib—TEK—head—gestational diabetes	0.00142	0.00236	CbGeAlD
Crizotinib—YES1—vagina—gestational diabetes	0.00142	0.00236	CbGeAlD
Crizotinib—STK10—vagina—gestational diabetes	0.0014	0.00234	CbGeAlD
Crizotinib—TAOK3—vagina—gestational diabetes	0.0014	0.00233	CbGeAlD
Crizotinib—EPHB6—head—gestational diabetes	0.00136	0.00226	CbGeAlD
Crizotinib—YES1—head—gestational diabetes	0.00131	0.00218	CbGeAlD
Crizotinib—STK10—head—gestational diabetes	0.0013	0.00216	CbGeAlD
Crizotinib—TAOK3—head—gestational diabetes	0.00129	0.00215	CbGeAlD
Crizotinib—SRC—head—gestational diabetes	0.00126	0.0021	CbGeAlD
Crizotinib—CSF1R—vagina—gestational diabetes	0.00122	0.00204	CbGeAlD
Crizotinib—ABL1—uterus—gestational diabetes	0.00119	0.00198	CbGeAlD
Crizotinib—ABL1—adipose tissue—gestational diabetes	0.00116	0.00194	CbGeAlD
Crizotinib—CSF1R—head—gestational diabetes	0.00113	0.00188	CbGeAlD
Crizotinib—CYP3A5—islet of Langerhans—gestational diabetes	0.00107	0.00178	CbGeAlD
Crizotinib—ABL1—vagina—gestational diabetes	0.000968	0.00161	CbGeAlD
Crizotinib—ABL1—head—gestational diabetes	0.000894	0.00149	CbGeAlD
Crizotinib—CYP3A5—adipose tissue—gestational diabetes	0.000681	0.00113	CbGeAlD
Crizotinib—Hepatic function abnormal—Glyburide—gestational diabetes	0.000644	0.0852	CcSEcCtD
Crizotinib—Hepatic failure—Glyburide—gestational diabetes	0.000626	0.0829	CcSEcCtD
Crizotinib—Visual disturbance—Glyburide—gestational diabetes	0.000594	0.0786	CcSEcCtD
Crizotinib—ABCB1—islet of Langerhans—gestational diabetes	0.000568	0.000945	CbGeAlD
Crizotinib—CYP3A5—vagina—gestational diabetes	0.000567	0.000943	CbGeAlD
Crizotinib—Diplopia—Glyburide—gestational diabetes	0.000563	0.0745	CcSEcCtD
Crizotinib—ABCB1—embryo—gestational diabetes	0.000549	0.000914	CbGeAlD
Crizotinib—Visual impairment—Glyburide—gestational diabetes	0.000375	0.0497	CcSEcCtD
Crizotinib—ABCB1—uterus—gestational diabetes	0.00037	0.000616	CbGeAlD
Crizotinib—Eye disorder—Glyburide—gestational diabetes	0.000364	0.0482	CcSEcCtD
Crizotinib—ABCB1—adipose tissue—gestational diabetes	0.000362	0.000603	CbGeAlD
Crizotinib—Malnutrition—Glyburide—gestational diabetes	0.000339	0.0449	CcSEcCtD
Crizotinib—Vision blurred—Glyburide—gestational diabetes	0.000319	0.0423	CcSEcCtD
Crizotinib—Anaemia—Glyburide—gestational diabetes	0.000313	0.0415	CcSEcCtD
Crizotinib—Leukopenia—Glyburide—gestational diabetes	0.000303	0.0401	CcSEcCtD
Crizotinib—ABCB1—vagina—gestational diabetes	0.000301	0.000501	CbGeAlD
Crizotinib—ABCB1—head—gestational diabetes	0.000278	0.000463	CbGeAlD
Crizotinib—Oedema—Glyburide—gestational diabetes	0.000277	0.0366	CcSEcCtD
Crizotinib—Shock—Glyburide—gestational diabetes	0.000272	0.036	CcSEcCtD
Crizotinib—Nervous system disorder—Glyburide—gestational diabetes	0.000271	0.0359	CcSEcCtD
Crizotinib—Paraesthesia—Glyburide—gestational diabetes	0.000248	0.0329	CcSEcCtD
Crizotinib—Dyspnoea—Glyburide—gestational diabetes	0.000247	0.0326	CcSEcCtD
Crizotinib—Dyspepsia—Glyburide—gestational diabetes	0.000244	0.0322	CcSEcCtD
Crizotinib—Decreased appetite—Glyburide—gestational diabetes	0.00024	0.0318	CcSEcCtD
Crizotinib—Gastrointestinal disorder—Glyburide—gestational diabetes	0.000239	0.0316	CcSEcCtD
Crizotinib—JAK2—Signaling by FGFR in disease—FGF2—gestational diabetes	0.000223	0.00057	CbGpPWpGaD
Crizotinib—JAK2—DAP12 interactions—FGF2—gestational diabetes	0.000223	0.00057	CbGpPWpGaD
Crizotinib—JAK2—Fc epsilon receptor (FCERI) signaling—FGF2—gestational diabetes	0.000223	0.00057	CbGpPWpGaD
Crizotinib—LYN—Developmental Biology—ADIPOQ—gestational diabetes	0.000222	0.000568	CbGpPWpGaD
Crizotinib—ABL1—Developmental Biology—ADIPOQ—gestational diabetes	0.000221	0.000565	CbGpPWpGaD
Crizotinib—JAK2—Signaling by EGFR—FGF2—gestational diabetes	0.000221	0.000565	CbGpPWpGaD
Crizotinib—LCK—Signaling by ERBB4—FGF2—gestational diabetes	0.000221	0.000564	CbGpPWpGaD
Crizotinib—LYN—B Cell Activation—FGF2—gestational diabetes	0.000221	0.000563	CbGpPWpGaD
Crizotinib—PTK2—Apoptosis—TNF—gestational diabetes	0.00022	0.000561	CbGpPWpGaD
Crizotinib—JAK2—Signaling by EGFR in Cancer—FGF2—gestational diabetes	0.000219	0.00056	CbGpPWpGaD
Crizotinib—JAK2—Signaling by PDGF—FGF2—gestational diabetes	0.000218	0.000557	CbGpPWpGaD
Crizotinib—LCK—Innate Immune System—MBL2—gestational diabetes	0.000218	0.000555	CbGpPWpGaD
Crizotinib—MET—Developmental Biology—TNF—gestational diabetes	0.000217	0.000555	CbGpPWpGaD
Crizotinib—TYK2—Signaling by GPCR—MTNR1B—gestational diabetes	0.000216	0.000552	CbGpPWpGaD
Crizotinib—STK3—Signaling Pathways—LEP—gestational diabetes	0.000215	0.000549	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—LEPR—gestational diabetes	0.000214	0.000546	CbGpPWpGaD
Crizotinib—LCK—Downstream signal transduction—FGF2—gestational diabetes	0.000211	0.000538	CbGpPWpGaD
Crizotinib—PTK2—Immune System—MBL2—gestational diabetes	0.00021	0.000537	CbGpPWpGaD
Crizotinib—LCK—Signaling by FGFR—FGF2—gestational diabetes	0.00021	0.000536	CbGpPWpGaD
Crizotinib—LCK—Signaling by ERBB2—FGF2—gestational diabetes	0.000209	0.000533	CbGpPWpGaD
Crizotinib—JAK2—Developmental Biology—ADIPOQ—gestational diabetes	0.000208	0.000531	CbGpPWpGaD
Crizotinib—LCK—DAP12 signaling—FGF2—gestational diabetes	0.000208	0.00053	CbGpPWpGaD
Crizotinib—SRC—Signaling by SCF-KIT—FGF2—gestational diabetes	0.000208	0.00053	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—LEPR—gestational diabetes	0.000207	0.000529	CbGpPWpGaD
Crizotinib—YES1—Immune System—MBL2—gestational diabetes	0.000207	0.000529	CbGpPWpGaD
Crizotinib—IRAK1—Signaling by NGF—FGF2—gestational diabetes	0.000207	0.000528	CbGpPWpGaD
Crizotinib—TXK—Immune System—FGF2—gestational diabetes	0.000206	0.000526	CbGpPWpGaD
Crizotinib—LCK—Downstream signaling events of B Cell Receptor (BCR)—FGF2—gestational diabetes	0.000205	0.000523	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—MTNR1B—gestational diabetes	0.000201	0.000513	CbGpPWpGaD
Crizotinib—TYK2—Signaling by NGF—FGF2—gestational diabetes	0.000201	0.000512	CbGpPWpGaD
Crizotinib—TBK1—Innate Immune System—FGF2—gestational diabetes	0.000199	0.000509	CbGpPWpGaD
Crizotinib—Asthenia—Glyburide—gestational diabetes	0.000198	0.0263	CcSEcCtD
Crizotinib—JAK2—NGF signalling via TRKA from the plasma membrane—FGF2—gestational diabetes	0.000198	0.000505	CbGpPWpGaD
Crizotinib—IRAK1—Immune System—MBL2—gestational diabetes	0.000197	0.000502	CbGpPWpGaD
Crizotinib—SRC—Developmental Biology—GCK—gestational diabetes	0.000196	0.0005	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—RBP4—gestational diabetes	0.000196	0.0005	CbGpPWpGaD
Crizotinib—LCK—Fc epsilon receptor (FCERI) signaling—FGF2—gestational diabetes	0.000196	0.000499	CbGpPWpGaD
Crizotinib—LCK—DAP12 interactions—FGF2—gestational diabetes	0.000196	0.000499	CbGpPWpGaD
Crizotinib—LCK—Signaling by FGFR in disease—FGF2—gestational diabetes	0.000196	0.000499	CbGpPWpGaD
Crizotinib—LCK—Signaling by EGFR—FGF2—gestational diabetes	0.000194	0.000495	CbGpPWpGaD
Crizotinib—SRC—Innate Immune System—MBL2—gestational diabetes	0.000193	0.000492	CbGpPWpGaD
Crizotinib—STK4—Signaling Pathways—FGF2—gestational diabetes	0.000192	0.000491	CbGpPWpGaD
Crizotinib—LCK—Signaling by EGFR in Cancer—FGF2—gestational diabetes	0.000192	0.00049	CbGpPWpGaD
Crizotinib—LCK—Signaling by PDGF—FGF2—gestational diabetes	0.000191	0.000488	CbGpPWpGaD
Crizotinib—TYK2—Immune System—MBL2—gestational diabetes	0.000191	0.000487	CbGpPWpGaD
Crizotinib—FES—Developmental Biology—TNF—gestational diabetes	0.00019	0.000485	CbGpPWpGaD
Crizotinib—Diarrhoea—Glyburide—gestational diabetes	0.000189	0.025	CcSEcCtD
Crizotinib—PTK2—Developmental Biology—LEP—gestational diabetes	0.000188	0.000479	CbGpPWpGaD
Crizotinib—SRC—Downstream signal transduction—FGF2—gestational diabetes	0.000187	0.000477	CbGpPWpGaD
Crizotinib—SRC—Signaling by FGFR—FGF2—gestational diabetes	0.000186	0.000474	CbGpPWpGaD
Crizotinib—YES1—Developmental Biology—LEP—gestational diabetes	0.000185	0.000473	CbGpPWpGaD
Crizotinib—SRC—Signaling by ERBB2—FGF2—gestational diabetes	0.000185	0.000472	CbGpPWpGaD
Crizotinib—LCK—B Cell Activation—FGF2—gestational diabetes	0.000181	0.000462	CbGpPWpGaD
Crizotinib—JAK2—GPCR downstream signaling—MTNR1B—gestational diabetes	0.00018	0.00046	CbGpPWpGaD
Crizotinib—ACVR1B—Signaling Pathways—LEP—gestational diabetes	0.00018	0.00046	CbGpPWpGaD
Crizotinib—FER—Signaling Pathways—LEP—gestational diabetes	0.00018	0.00046	CbGpPWpGaD
Crizotinib—ABL2—Developmental Biology—TNF—gestational diabetes	0.00018	0.00046	CbGpPWpGaD
Crizotinib—EPHA5—Developmental Biology—TNF—gestational diabetes	0.00018	0.00046	CbGpPWpGaD
Crizotinib—EPHA3—Developmental Biology—TNF—gestational diabetes	0.00018	0.00046	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—MTNR1B—gestational diabetes	0.000179	0.000457	CbGpPWpGaD
Crizotinib—CDK7—Gene Expression—AR—gestational diabetes	0.000179	0.000456	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—LEPR—gestational diabetes	0.000178	0.000454	CbGpPWpGaD
Crizotinib—TYK2—Disease—RBP4—gestational diabetes	0.000178	0.000454	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—MTNR1B—gestational diabetes	0.000177	0.000451	CbGpPWpGaD
Crizotinib—ABCB1—Integrated Pancreatic Cancer Pathway—AR—gestational diabetes	0.000176	0.00045	CbGpPWpGaD
Crizotinib—Vomiting—Glyburide—gestational diabetes	0.000176	0.0233	CcSEcCtD
Crizotinib—YES1—Signaling Pathways—LEPR—gestational diabetes	0.000176	0.000448	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—RBP4—gestational diabetes	0.000175	0.000446	CbGpPWpGaD
Crizotinib—Rash—Glyburide—gestational diabetes	0.000174	0.0231	CcSEcCtD
Crizotinib—Dermatitis—Glyburide—gestational diabetes	0.000174	0.0231	CcSEcCtD
Crizotinib—EPHA8—Developmental Biology—TNF—gestational diabetes	0.000174	0.000444	CbGpPWpGaD
Crizotinib—LCK—NGF signalling via TRKA from the plasma membrane—FGF2—gestational diabetes	0.000173	0.000442	CbGpPWpGaD
Crizotinib—SRC—Signaling by FGFR in disease—FGF2—gestational diabetes	0.000173	0.000442	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—RBP4—gestational diabetes	0.000172	0.000439	CbGpPWpGaD
Crizotinib—LIMK2—Developmental Biology—TNF—gestational diabetes	0.000172	0.000439	CbGpPWpGaD
Crizotinib—EPHB4—Developmental Biology—TNF—gestational diabetes	0.000172	0.000439	CbGpPWpGaD
Crizotinib—EPHA4—Developmental Biology—TNF—gestational diabetes	0.000172	0.000439	CbGpPWpGaD
Crizotinib—SRC—Signaling by EGFR—FGF2—gestational diabetes	0.000172	0.000438	CbGpPWpGaD
Crizotinib—AXL—Signaling Pathways—LEP—gestational diabetes	0.000171	0.000436	CbGpPWpGaD
Crizotinib—TYK2—Developmental Biology—LEP—gestational diabetes	0.000171	0.000435	CbGpPWpGaD
Crizotinib—SRC—Signaling by EGFR in Cancer—FGF2—gestational diabetes	0.00017	0.000434	CbGpPWpGaD
Crizotinib—SRC—Signaling by PDGF—FGF2—gestational diabetes	0.000169	0.000432	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—MTNR1B—gestational diabetes	0.000169	0.000431	CbGpPWpGaD
Crizotinib—LIMK1—Developmental Biology—TNF—gestational diabetes	0.000168	0.000429	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—LEPR—gestational diabetes	0.000166	0.000425	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—RBP4—gestational diabetes	0.000165	0.00042	CbGpPWpGaD
Crizotinib—Nausea—Glyburide—gestational diabetes	0.000164	0.0217	CcSEcCtD
Crizotinib—RPS6KB1—Signaling Pathways—MTNR1B—gestational diabetes	0.000164	0.000418	CbGpPWpGaD
Crizotinib—JAK2—Signaling by GPCR—MTNR1B—gestational diabetes	0.000164	0.000418	CbGpPWpGaD
Crizotinib—STK3—Signaling Pathways—FGF2—gestational diabetes	0.000163	0.000417	CbGpPWpGaD
Crizotinib—SRC—Integrated Pancreatic Cancer Pathway—FGF2—gestational diabetes	0.000163	0.000416	CbGpPWpGaD
Crizotinib—EPHB6—Developmental Biology—TNF—gestational diabetes	0.000162	0.000412	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—LEPR—gestational diabetes	0.000162	0.000412	CbGpPWpGaD
Crizotinib—SRC—Developmental Biology—ADIPOQ—gestational diabetes	0.000161	0.000412	CbGpPWpGaD
Crizotinib—RIPK2—Innate Immune System—FGF2—gestational diabetes	0.000161	0.00041	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—RBP4—gestational diabetes	0.00016	0.000408	CbGpPWpGaD
Crizotinib—TYK2—Disease—NAMPT—gestational diabetes	0.000159	0.000407	CbGpPWpGaD
Crizotinib—TYK2—Disease—GCK—gestational diabetes	0.000158	0.000404	CbGpPWpGaD
Crizotinib—BMPR1B—Signaling Pathways—LEP—gestational diabetes	0.000156	0.000399	CbGpPWpGaD
Crizotinib—IKBKE—Immune System—FGF2—gestational diabetes	0.000156	0.000399	CbGpPWpGaD
Crizotinib—LYN—Immune System—MBL2—gestational diabetes	0.000155	0.000395	CbGpPWpGaD
Crizotinib—RIPK2—Adaptive Immune System—FGF2—gestational diabetes	0.000154	0.000394	CbGpPWpGaD
Crizotinib—FGR—Innate Immune System—FGF2—gestational diabetes	0.000154	0.000393	CbGpPWpGaD
Crizotinib—ABL1—Immune System—MBL2—gestational diabetes	0.000154	0.000393	CbGpPWpGaD
Crizotinib—SRC—NGF signalling via TRKA from the plasma membrane—FGF2—gestational diabetes	0.000153	0.000391	CbGpPWpGaD
Crizotinib—JAK2—Signaling by NGF—FGF2—gestational diabetes	0.000152	0.000388	CbGpPWpGaD
Crizotinib—EPHA6—Developmental Biology—TNF—gestational diabetes	0.000152	0.000388	CbGpPWpGaD
Crizotinib—BLK—Adaptive Immune System—FGF2—gestational diabetes	0.000148	0.000379	CbGpPWpGaD
Crizotinib—JAK2—Immune System—MBL2—gestational diabetes	0.000145	0.000369	CbGpPWpGaD
Crizotinib—PTK2—Developmental Biology—FGF2—gestational diabetes	0.000143	0.000364	CbGpPWpGaD
Crizotinib—MAPK7—Immune System—FGF2—gestational diabetes	0.000142	0.000363	CbGpPWpGaD
Crizotinib—LIMK1—Immune System—FGF2—gestational diabetes	0.000142	0.000363	CbGpPWpGaD
Crizotinib—YES1—Developmental Biology—FGF2—gestational diabetes	0.000141	0.000359	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—MTNR1B—gestational diabetes	0.000141	0.000359	CbGpPWpGaD
Crizotinib—EPHA2—Developmental Biology—TNF—gestational diabetes	0.00014	0.000358	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—MTNR1B—gestational diabetes	0.000139	0.000354	CbGpPWpGaD
Crizotinib—LYN—Developmental Biology—LEP—gestational diabetes	0.000138	0.000353	CbGpPWpGaD
Crizotinib—ABL1—Developmental Biology—LEP—gestational diabetes	0.000138	0.000351	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—RBP4—gestational diabetes	0.000137	0.00035	CbGpPWpGaD
Crizotinib—ACVR1B—Signaling Pathways—FGF2—gestational diabetes	0.000137	0.00035	CbGpPWpGaD
Crizotinib—FER—Signaling Pathways—FGF2—gestational diabetes	0.000137	0.00035	CbGpPWpGaD
Crizotinib—FES—Signaling Pathways—LEP—gestational diabetes	0.000137	0.000349	CbGpPWpGaD
Crizotinib—ABL1—Integrated Pancreatic Cancer Pathway—TNF—gestational diabetes	0.000136	0.000347	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—RBP4—gestational diabetes	0.000135	0.000345	CbGpPWpGaD
Crizotinib—JAK2—Disease—RBP4—gestational diabetes	0.000135	0.000344	CbGpPWpGaD
Crizotinib—LCK—Signaling by NGF—FGF2—gestational diabetes	0.000133	0.00034	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—MTNR1B—gestational diabetes	0.000132	0.000336	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—LEPR—gestational diabetes	0.000131	0.000334	CbGpPWpGaD
Crizotinib—AXL—Signaling Pathways—FGF2—gestational diabetes	0.00013	0.000331	CbGpPWpGaD
Crizotinib—TYK2—Developmental Biology—FGF2—gestational diabetes	0.00013	0.000331	CbGpPWpGaD
Crizotinib—JAK2—Developmental Biology—LEP—gestational diabetes	0.000129	0.00033	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—GGCT—gestational diabetes	0.000128	0.000328	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—RBP4—gestational diabetes	0.000128	0.000327	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—MTNR1B—gestational diabetes	0.000128	0.000326	CbGpPWpGaD
Crizotinib—LCK—Immune System—MBL2—gestational diabetes	0.000127	0.000323	CbGpPWpGaD
Crizotinib—PTK2—Innate Immune System—FGF2—gestational diabetes	0.000126	0.000322	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—RBP4—gestational diabetes	0.000124	0.000318	CbGpPWpGaD
Crizotinib—YES1—Innate Immune System—FGF2—gestational diabetes	0.000124	0.000317	CbGpPWpGaD
Crizotinib—IGF1R—Signaling Pathways—LEP—gestational diabetes	0.000124	0.000315	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—LEPR—gestational diabetes	0.000122	0.000312	CbGpPWpGaD
Crizotinib—CYP3A4—Biological oxidations—CYP19A1—gestational diabetes	0.000122	0.00031	CbGpPWpGaD
Crizotinib—MAPK7—Signaling Pathways—LEP—gestational diabetes	0.000121	0.000309	CbGpPWpGaD
Crizotinib—JAK2—Disease—NAMPT—gestational diabetes	0.000121	0.000308	CbGpPWpGaD
Crizotinib—JAK2—Disease—GCK—gestational diabetes	0.00012	0.000306	CbGpPWpGaD
Crizotinib—CYP3A4—Metapathway biotransformation—CYP19A1—gestational diabetes	0.00012	0.000306	CbGpPWpGaD
Crizotinib—YES1—Adaptive Immune System—FGF2—gestational diabetes	0.000119	0.000305	CbGpPWpGaD
Crizotinib—ABCB1—Allograft Rejection—TNF—gestational diabetes	0.000119	0.000303	CbGpPWpGaD
Crizotinib—BMPR1B—Signaling Pathways—FGF2—gestational diabetes	0.000119	0.000303	CbGpPWpGaD
Crizotinib—LCK—Disease—RBP4—gestational diabetes	0.000118	0.000301	CbGpPWpGaD
Crizotinib—SRC—Signaling by NGF—FGF2—gestational diabetes	0.000118	0.000301	CbGpPWpGaD
Crizotinib—IRAK1—Innate Immune System—FGF2—gestational diabetes	0.000118	0.000301	CbGpPWpGaD
Crizotinib—TBK1—Immune System—FGF2—gestational diabetes	0.000116	0.000296	CbGpPWpGaD
Crizotinib—TYK2—Innate Immune System—FGF2—gestational diabetes	0.000114	0.000292	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—GLS2—gestational diabetes	0.000112	0.000286	CbGpPWpGaD
Crizotinib—SRC—Immune System—MBL2—gestational diabetes	0.000112	0.000286	CbGpPWpGaD
Crizotinib—MAP3K3—Immune System—FGF2—gestational diabetes	0.000111	0.000284	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—LEPR—gestational diabetes	0.000107	0.000274	CbGpPWpGaD
Crizotinib—LCK—Disease—NAMPT—gestational diabetes	0.000106	0.00027	CbGpPWpGaD
Crizotinib—LCK—Disease—GCK—gestational diabetes	0.000105	0.000268	CbGpPWpGaD
Crizotinib—JAK3—Immune System—FGF2—gestational diabetes	0.000105	0.000268	CbGpPWpGaD
Crizotinib—LYN—Developmental Biology—FGF2—gestational diabetes	0.000105	0.000268	CbGpPWpGaD
Crizotinib—ABL1—Developmental Biology—FGF2—gestational diabetes	0.000104	0.000267	CbGpPWpGaD
Crizotinib—SRC—Disease—RBP4—gestational diabetes	0.000104	0.000267	CbGpPWpGaD
Crizotinib—FES—Signaling Pathways—FGF2—gestational diabetes	0.000104	0.000265	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—MTNR1B—gestational diabetes	0.000103	0.000264	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—RBP4—gestational diabetes	0.000101	0.000257	CbGpPWpGaD
Crizotinib—SRC—Developmental Biology—LEP—gestational diabetes	0.0001	0.000256	CbGpPWpGaD
Crizotinib—SRC—Integrated Pancreatic Cancer Pathway—TNF—gestational diabetes	9.92e-05	0.000253	CbGpPWpGaD
Crizotinib—ABCB1—Transmembrane transport of small molecules—GCK—gestational diabetes	9.85e-05	0.000251	CbGpPWpGaD
Crizotinib—JAK2—Developmental Biology—FGF2—gestational diabetes	9.82e-05	0.000251	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—GGCT—gestational diabetes	9.69e-05	0.000247	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—MTNR1B—gestational diabetes	9.68e-05	0.000247	CbGpPWpGaD
Crizotinib—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—gestational diabetes	9.64e-05	0.000246	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—LEPR—gestational diabetes	9.5e-05	0.000242	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—RBP4—gestational diabetes	9.43e-05	0.000241	CbGpPWpGaD
Crizotinib—IGF1R—Signaling Pathways—FGF2—gestational diabetes	9.39e-05	0.00024	CbGpPWpGaD
Crizotinib—SRC—Disease—NAMPT—gestational diabetes	9.37e-05	0.000239	CbGpPWpGaD
Crizotinib—RIPK2—Immune System—FGF2—gestational diabetes	9.36e-05	0.000239	CbGpPWpGaD
Crizotinib—SRC—Disease—GCK—gestational diabetes	9.31e-05	0.000238	CbGpPWpGaD
Crizotinib—LYN—Innate Immune System—FGF2—gestational diabetes	9.27e-05	0.000237	CbGpPWpGaD
Crizotinib—ABL1—Innate Immune System—FGF2—gestational diabetes	9.23e-05	0.000235	CbGpPWpGaD
Crizotinib—PTK2B—Immune System—FGF2—gestational diabetes	9.22e-05	0.000235	CbGpPWpGaD
Crizotinib—MAPK7—Signaling Pathways—FGF2—gestational diabetes	9.19e-05	0.000234	CbGpPWpGaD
Crizotinib—CDK7—Disease—FGF2—gestational diabetes	9.06e-05	0.000231	CbGpPWpGaD
Crizotinib—BLK—Immune System—FGF2—gestational diabetes	9e-05	0.00023	CbGpPWpGaD
Crizotinib—FGR—Immune System—FGF2—gestational diabetes	8.97e-05	0.000229	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—LEP—gestational diabetes	8.94e-05	0.000228	CbGpPWpGaD
Crizotinib—LYN—Adaptive Immune System—FGF2—gestational diabetes	8.9e-05	0.000227	CbGpPWpGaD
Crizotinib—PTK2—Developmental Biology—TNF—gestational diabetes	8.69e-05	0.000222	CbGpPWpGaD
Crizotinib—JAK2—Innate Immune System—FGF2—gestational diabetes	8.68e-05	0.000221	CbGpPWpGaD
Crizotinib—YES1—Developmental Biology—TNF—gestational diabetes	8.57e-05	0.000219	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—MTNR1B—gestational diabetes	8.48e-05	0.000216	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—GLS2—gestational diabetes	8.47e-05	0.000216	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—RBP4—gestational diabetes	8.26e-05	0.000211	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—LEP—gestational diabetes	7.96e-05	0.000203	CbGpPWpGaD
Crizotinib—TYK2—Developmental Biology—TNF—gestational diabetes	7.89e-05	0.000201	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—LEP—gestational diabetes	7.85e-05	0.0002	CbGpPWpGaD
Crizotinib—SRC—Developmental Biology—FGF2—gestational diabetes	7.62e-05	0.000194	CbGpPWpGaD
Crizotinib—LCK—Innate Immune System—FGF2—gestational diabetes	7.6e-05	0.000194	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—LEP—gestational diabetes	7.51e-05	0.000192	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—MTNR1B—gestational diabetes	7.51e-05	0.000192	CbGpPWpGaD
Crizotinib—PTK2—Immune System—FGF2—gestational diabetes	7.34e-05	0.000187	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—RBP4—gestational diabetes	7.31e-05	0.000187	CbGpPWpGaD
Crizotinib—LCK—Adaptive Immune System—FGF2—gestational diabetes	7.3e-05	0.000186	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—LEP—gestational diabetes	7.28e-05	0.000186	CbGpPWpGaD
Crizotinib—YES1—Immune System—FGF2—gestational diabetes	7.24e-05	0.000185	CbGpPWpGaD
Crizotinib—IRAK1—Immune System—FGF2—gestational diabetes	6.87e-05	0.000175	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—FGF2—gestational diabetes	6.79e-05	0.000173	CbGpPWpGaD
Crizotinib—SRC—Innate Immune System—FGF2—gestational diabetes	6.73e-05	0.000172	CbGpPWpGaD
Crizotinib—TYK2—Immune System—FGF2—gestational diabetes	6.67e-05	0.00017	CbGpPWpGaD
Crizotinib—SRC—Adaptive Immune System—FGF2—gestational diabetes	6.46e-05	0.000165	CbGpPWpGaD
Crizotinib—LYN—Developmental Biology—TNF—gestational diabetes	6.39e-05	0.000163	CbGpPWpGaD
Crizotinib—ABL1—Developmental Biology—TNF—gestational diabetes	6.36e-05	0.000162	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—LEP—gestational diabetes	6.25e-05	0.000159	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—LEP—gestational diabetes	6.16e-05	0.000157	CbGpPWpGaD
Crizotinib—TYK2—Disease—FGF2—gestational diabetes	6.16e-05	0.000157	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—NAMPT—gestational diabetes	6.15e-05	0.000157	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—GCK—gestational diabetes	6.11e-05	0.000156	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—FGF2—gestational diabetes	6.05e-05	0.000154	CbGpPWpGaD
Crizotinib—JAK2—Developmental Biology—TNF—gestational diabetes	5.98e-05	0.000153	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—GGCT—gestational diabetes	5.97e-05	0.000152	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—FGF2—gestational diabetes	5.96e-05	0.000152	CbGpPWpGaD
Crizotinib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—gestational diabetes	5.87e-05	0.00015	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—LEP—gestational diabetes	5.85e-05	0.000149	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—FGF2—gestational diabetes	5.71e-05	0.000146	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—LEP—gestational diabetes	5.68e-05	0.000145	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—FGF2—gestational diabetes	5.53e-05	0.000141	CbGpPWpGaD
Crizotinib—LYN—Immune System—FGF2—gestational diabetes	5.4e-05	0.000138	CbGpPWpGaD
Crizotinib—ABL1—Immune System—FGF2—gestational diabetes	5.37e-05	0.000137	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—GLS2—gestational diabetes	5.22e-05	0.000133	CbGpPWpGaD
Crizotinib—JAK2—Immune System—FGF2—gestational diabetes	5.05e-05	0.000129	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—FGF2—gestational diabetes	4.75e-05	0.000121	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—FGF2—gestational diabetes	4.68e-05	0.000119	CbGpPWpGaD
Crizotinib—JAK2—Disease—FGF2—gestational diabetes	4.67e-05	0.000119	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—NAMPT—gestational diabetes	4.64e-05	0.000118	CbGpPWpGaD
Crizotinib—SRC—Developmental Biology—TNF—gestational diabetes	4.64e-05	0.000118	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—GCK—gestational diabetes	4.61e-05	0.000118	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—LEP—gestational diabetes	4.6e-05	0.000117	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—CYP19A1—gestational diabetes	4.47e-05	0.000114	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—FGF2—gestational diabetes	4.44e-05	0.000113	CbGpPWpGaD
Crizotinib—LCK—Immune System—FGF2—gestational diabetes	4.43e-05	0.000113	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—FGF2—gestational diabetes	4.31e-05	0.00011	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—LEP—gestational diabetes	4.3e-05	0.00011	CbGpPWpGaD
Crizotinib—LCK—Disease—FGF2—gestational diabetes	4.09e-05	0.000104	CbGpPWpGaD
Crizotinib—SRC—Immune System—FGF2—gestational diabetes	3.92e-05	0.0001	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—LEP—gestational diabetes	3.77e-05	9.61e-05	CbGpPWpGaD
Crizotinib—SRC—Disease—FGF2—gestational diabetes	3.62e-05	9.23e-05	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—FGF2—gestational diabetes	3.49e-05	8.91e-05	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—CYP19A1—gestational diabetes	3.37e-05	8.61e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—LEP—gestational diabetes	3.33e-05	8.51e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—FGF2—gestational diabetes	3.27e-05	8.34e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—FGF2—gestational diabetes	2.86e-05	7.3e-05	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—NAMPT—gestational diabetes	2.86e-05	7.3e-05	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—GCK—gestational diabetes	2.84e-05	7.25e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—FGF2—gestational diabetes	2.53e-05	6.46e-05	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—CYP19A1—gestational diabetes	2.08e-05	5.3e-05	CbGpPWpGaD
